Group 6 Copy 98
0
    Please wait...

    About This Project

    OncoSynergy, Inc.
    The Ebola outbreak in west Africa has been declared a global emergency by the WHO with over 1,000 victims and no approved therapies. OncoSynergy is developing a readily manufactured experimental cancer drug, OS2966, which coincidentally targets the receptor hijacked by ebola to infect cells. This project aims to demonstrate that OS2966 inhibits ebola infection of human cells thus providing the impetus for expediting OS2966 for treatment of ebola.
    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    The Mystery of the Disappearing Seabirds: Using Science to Protect Caribbean Seabirds

    Seabirds are among the most endangered of all vertebrate groups. Loss of Caribbean populations is ongoing; many...

    Join the Journey: Golden-winged Warbler Migration

    Donate to our U Maine gift account. Golden-winged Warbler is one of North America's fastest declining forest...

    Do differences in coral skeletal architecture influence bleaching susceptibility?

    Reef-building corals are bleaching and dying at unprecedented rates due to ocean warming. However, corals bleach...

    Backer Badge Funded

    A biology project funded by 47 people